15 items found

Organisations: RISIS2OpenData Groups: Restricted Access Tags: 69999 Biological Sciences not elsewhere classified Pharmacology keywords.General Medicine

Filter Results
  • publication

    Medication therapy strategies for the coronavirus disease 2019 (COVID-19): re...

    The coronavirus disease 2019 (COVID-19) pandemic has spread globally since it outbroke in December 2019. The urgent pandemic presents an unprecedented challenge to develop and...
  • publication

    Systematic literature review of the epidemiology and clinical burden of chron...

    We conducted a systematic literature review (SLR) to determine the epidemiology and clinical burden of chronic rhinosinusitis with nasal polyps (CRSwNP) and to describe how the...
  • publication

    The Combined Effects of Immediate and Delayed Positive Reinforcement to Incre...

    Background: While positive reinforcement is perhaps the most common component in interventions for feeding problems, the literature suggests it is not sufficient to address more...
  • publication

    An appraisal of pivotal evaluation designs in validating noninvasive biomarke...

    An appraisal of pivotal evaluation designs in validating noninvasive biomarkers for head and neck cancer detection
  • publication

    Association of tenofovir disoproxil fumarate exposure with chronic kidney dis...

    Tenofovir disoproxil fumarate (TDF)-based regimens have been associated with impaired kidney function and loss of bone mineral density among patients living with HIV (PLWH). We...
  • publication

    Renal complications in COVID-19: a systematic review and meta-analysis

    Emerging data suggest that coronavirus disease 2019 (COVID-19) has extrapulmonary manifestations but its renal manifestations are not clearly defined. We aimed to evaluate renal...
  • publication

    dedup_wf_001--b2aea697ee420d2a6a886a8155e8b204

    The β-D-Mannuronic acid (M2000) as a novel immunosuppressive drug, patented (PCT/EP2017/067920), has shown positive effects in experimental model of multiple sclerosis (MS). In...
  • publication

    Respiratory depression following medications for opioid use disorder (MOUD)-a...

    Medications for opioid use disorder (MOUD) including buprenorphine is recommended for patients with opioid use disorders. We sought to evaluate the frequencies of respiratory...
  • publication

    Genetic factors in anthracycline-induced cardiotoxicity in patients treated f...

    Cardiovascular diseases are the main cause of treatment-related morbidity and mortality in childhood cancer patients. Anthracyclines, one of the most common chemotherapeutic...
  • publication

    Factors associated with prolonged time to treatment failure with fulvestrant ...

    Objective: The JBCRG-C06 Safari study showed that earlier fulvestrant 500 mg (F500) use, a longer time from diagnosis to F500 use, and no prior palliative chemotherapy were...
  • publication

    Verification of the hemolysis index measurement: imprecision, accuracy, measu...

    Automated spectrophotometric measurement of hemolysis index (HI) allows rapid and cost-effective assessment of hemolysis interference. We evaluated the analytical performance of...
  • publication

    Impact of immunogenicity on efficacy and tolerability of tumour necrosis fact...

    SB4, SB2, and SB5 are biosimilars of etanercept (ETN), infliximab (INF), and adalimumab (ADA), respectively. This pooled analysis evaluated the immunogenicity of these...
  • publication

    Pamidronate in chronic non-bacterial osteomyelitis:a randomized, double-blind...

    Objective: This is the first randomized double-blinded, placebo-controlled pilot trial to investigate the efficacy of pamidronate in reducing radiological and clinical disease...
  • publication

    Immune-mediated inflammatory disease patients' preferences in adverse drug re...

    Objectives: Patient-reported outcomes (PROs) are increasingly used in studies and medical practice to obtain information on patients’ perspectives toward their treatment or...
  • publication

    Anti-HCV prevalence and risk factor-based screening for hepatitis C in pregna...

    The hepatitis C virus (HCV) prevalence in Sweden is estimated to be <0.5%, but unclear in pregnant women. The dominating route of transmission is drug use (DU), blood...